JP2015536947A5 - - Google Patents

Download PDF

Info

Publication number
JP2015536947A5
JP2015536947A5 JP2015540764A JP2015540764A JP2015536947A5 JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5 JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015540764 A JP2015540764 A JP 2015540764A JP 2015536947 A5 JP2015536947 A5 JP 2015536947A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound according
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540764A
Other languages
English (en)
Japanese (ja)
Other versions
JP6482466B2 (ja
JP2015536947A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067673 external-priority patent/WO2014070978A1/en
Publication of JP2015536947A publication Critical patent/JP2015536947A/ja
Publication of JP2015536947A5 publication Critical patent/JP2015536947A5/ja
Application granted granted Critical
Publication of JP6482466B2 publication Critical patent/JP6482466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540764A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6482466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722151P 2012-11-03 2012-11-03
US61/722,151 2012-11-03
PCT/US2013/067673 WO2014070978A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2015536947A JP2015536947A (ja) 2015-12-24
JP2015536947A5 true JP2015536947A5 (enExample) 2016-12-15
JP6482466B2 JP6482466B2 (ja) 2019-03-13

Family

ID=49620280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540764A Active JP6482466B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9284310B2 (enExample)
EP (1) EP2914591B1 (enExample)
JP (1) JP6482466B2 (enExample)
WO (1) WO2014070978A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2988306A1 (en) 2015-06-05 2016-12-08 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
PL3442974T3 (pl) 2016-04-15 2023-12-04 Elanco Animal Health Gmbh Pochodne pirazolopirymidyny
EP3720853A1 (de) * 2017-12-04 2020-10-14 Bayer CropScience Aktiengesellschaft 3-amino-[1,2,4]-triazolderivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
CN108003062B (zh) * 2017-12-25 2020-08-11 常州吉恩药业有限公司 一种单boc保护双氨基化合物的合成方法
CN112996789B (zh) 2018-09-12 2025-11-11 诺华股份有限公司 抗病毒吡啶并吡嗪二酮化合物
AR118243A1 (es) 2019-03-07 2021-09-22 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
AR119140A1 (es) 2019-06-13 2021-11-24 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
CA3145062C (en) * 2019-06-25 2024-07-02 Microbiotix, Inc. COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF EYE INFECTIONS WITH FILOCICLOVIR
WO2021033141A1 (en) 2019-08-20 2021-02-25 Pi Industries Ltd. Fused heterocyclic compounds and their use as pest control agents
EP4034537A1 (en) 2019-09-26 2022-08-03 Novartis AG Antiviral pyrazolopyridinone compounds
AR121344A1 (es) 2020-02-18 2022-05-11 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas
TW202334117A (zh) 2020-08-24 2023-09-01 美商達薩瑪治療公司 Sarm1之抑制劑
TW202304919A (zh) 2021-03-31 2023-02-01 印度商皮埃企業有限公司 稠合雜環化合物及其作為害蟲控制劑之用途
PE20251179A1 (es) 2022-04-22 2025-04-23 Vertex Pharma Compuestos de heteroarilo para el tratamiento del dolor
WO2025177310A1 (en) 2024-02-23 2025-08-28 Pi Industries Ltd. Fused heterocyclic compounds and its uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332725A (zh) 1998-12-09 2002-01-23 美国家庭用品有限公司 疱疹病毒的硫脲抑制剂
TR200101664T2 (tr) * 1998-12-09 2002-03-21 American Home Products Corporation Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
EA200100639A1 (ru) * 1998-12-09 2002-06-27 Американ Хоум Продактс Корпорейшн Производные тиомочевины, содержащие гетероциклический карбоксамид и защитную группу фенилэтиленамина, в качестве ингибиторов вирусов герпеса
EP1383749B1 (de) * 2001-04-19 2005-11-02 Bayer HealthCare AG Arylsulfonamide als antivirale mittel
JP2006512314A (ja) 2002-11-01 2006-04-13 バーテックス ファーマシューティカルズ インコーポレイテッド Jakインヒビターおよび他のプロテインキナーゼインヒビターとしての組成物の使用
SE0203654D0 (sv) * 2002-12-09 2002-12-09 Astrazeneca Ab New compounds
US20040248850A1 (en) 2003-02-11 2004-12-09 Kemia, Inc. Compounds for the treatment of HIV infection
US20090196912A1 (en) 2004-07-30 2009-08-06 Gpc Botech Ag Pyridinylamines
JP2009500347A (ja) 2005-06-30 2009-01-08 アムジエン・インコーポレーテツド ビスアリールキナーゼ阻害剤及びこれらの炎症、血管新生及び癌の治療における使用
US20090069288A1 (en) * 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
US20110294853A1 (en) 2008-09-12 2011-12-01 Benjamin Pelcman Bis Aromatic Compounds for Use in the Treatment of Inflammation
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2379075A4 (en) 2008-12-16 2012-05-30 Merck Sharp & Dohme TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
US20130109682A1 (en) 2010-07-06 2013-05-02 Novartis Ag Cyclic ether compounds useful as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2015536947A5 (enExample)
JP2016503403A5 (enExample)
JP2014520767A5 (enExample)
JP2019501125A5 (enExample)
JP2016505614A5 (enExample)
JP2015500843A5 (enExample)
JP2016530259A5 (enExample)
JP2018533593A5 (enExample)
JP2016516043A5 (enExample)
JP2012092103A5 (enExample)
JP2013523614A5 (enExample)
JP2014508811A5 (enExample)
JP2017501237A5 (enExample)
JP2015504081A5 (enExample)
JP2013537203A5 (enExample)
JP2012506389A5 (enExample)
JP2016503052A5 (enExample)
JP2014526533A5 (enExample)
JP2015522650A5 (enExample)
JP2015500842A5 (enExample)
RU2013108348A (ru) Конденсированные гетероарилы и их применение
JP2014500296A5 (enExample)
JP2017537937A5 (enExample)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
JP2016513122A5 (enExample)